Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%
NDC Package 0404-0175-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Maxiclens Chlorhexidine Gluconate Liquid Solution, 4% is usessurgical hand scrub: significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care healthcare personnel handwash: handwash to help reduce bacteria that potentially can cause disease skin wound and general skin cleanser: helps reduce bacteria on the skin. Marketed by Henry Schein, Inc., this product is identified by NDC 0404-0175 and is authorized under FDA application NDA019258.

Identification & Billing

NDC Package Code
0404-0175-02
Package Description
946 mL in 1 BOTTLE
Product Code
0404-0175
11-Digit Billing Format
00404017502
RxNorm Crosswalk
  • RxCUI: 211365 - chlorhexidine gluconate 4 % Medicated Liquid Soap
  • RxCUI: 211365 - chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap
  • RxCUI: 211365 - chlorhexidine gluconate 4 % Medicated Surgical Scrub
  • RxCUI: 2630838 - Maxiclens 4 % Medicated Liquid Soap
  • RxCUI: 2630838 - chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap [Maxiclens]

Clinical Specifications

Proprietary Name
Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%
Dosage Form
-
Usage Information
Usessurgical hand scrub: significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care healthcare personnel handwash: handwash to help reduce bacteria that potentially can cause disease skin wound and general skin cleanser: helps reduce bacteria on the skin

Regulatory & Marketing

Labeler Name
Henry Schein, Inc.
FDA Application #
NDA019258
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-17-2021
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0404-0175-02 identifies a specific commercial package of 946 ml in 1 bottle of Maxiclens Chlorhexidine Gluconate Liquid Solution, 4%, labeled by Henry Schein, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Henry Schein, Inc. on November 17, 2021. The current certification is valid through December 31, 2025.

How is this Henry Schein, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00404017502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0404-0175-02
11-Digit CMS (5-4-2)
00404-0175-02

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.